M1 Kliniken AG (M12.DE) — Stock Score Summary

M1 Kliniken AG (M12.DE) has a MoatMap StockRank of 98/100 based on Quality (72/100), Value (66/100), and Momentum (56/100) factor scores. The current signal is STRONG BUY. M1 Kliniken AG, operating in aesthetic medicine, does not have a clear and powerful macro tailwind creating asymmetric risk-reward that the market has not fully priced. While it may be a decent quality business in its niche, it lacks the Druckenmiller-style macro inflection point for high-conviction investment in this portfolio.

Key Financial Metrics

Price$22.12
Market Cap$414M
P/E (TTM)20.08
P/E (Forward)17.04
Price/Book3.00
Return on Equity13.9%
Return on Invested Capital19.6%
Debt/Equity12.74
Gross Margin13.4%
Operating Margin9.8%
Revenue Growth9.4%
Dividend Yield6.3%
Free Cash Flow$53M

M1 Kliniken AG operates in the Medical Distribution industry, part of the Healthcare sector (Germany).

Frequently Asked Questions

What is M1 Kliniken AG’s (M12.DE) StockRank?
MoatMap’s StockRank for M1 Kliniken AG (M12.DE) is 98/100, with a Strong Buy signal. It is a composite of Quality (72), Value (66), and Momentum (56) factor ranks across MoatMap’s 19,000+ stock universe.
Does M1 Kliniken AG have an economic moat?
M1 Kliniken AG (M12.DE) has a Quality factor score of 72/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is M1 Kliniken AG a buy, hold, or sell?
MoatMap’s current signal for M1 Kliniken AG (M12.DE) is Strong Buy, based on a StockRank of 98/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is M1 Kliniken AG in?
M1 Kliniken AG (M12.DE) operates in the Healthcare sector, specifically the Medical Distribution industry (Germany).
Browse all ranked stocksM12.DE deep dive reportAI ChampionsHow we score stocksSense-check another stock